Studio prospettico a sei mesi sugli effetti di un prodotto topico in lozione e shampoo a base di timo-peptidi di sintesi a basso peso molecolare nel telogen effluvium cronico e nell'AGA iniziale della donna

Translated title of the contribution: Clinical investigation of the effects of topical lotion and shampoo containing synthetic thymus peptides on androgenetic alopecia and chronic telogen effluvium in women after a six month-period treatment

Andreassi Maria Gabrielle, Barba Annalisa, Barbaso Daniela, Bassissi Paola, Belloli Cristiana, Benedetti Maria Cristiana, Bertazzoni Marina, Cannavò Patrizia, Cantù Alessandra Maria, Capezzera Rossana, Caporicci Giuliana, Carmagnola Anna, Ciuffreda Adriana, Cocciò Giovanna, Costa Carla Maria, De Padova Maria Pia, Di Landro Anna, Domaneschi Elisabetta, Fabbrocini Gabriella, Ferrara Caterina & 14 others Fileccia Piera, Giuliano Giuseppina, Lapucci Ezia, Lazzerini Sabrina, Mazzola Giuseppina, Montalbano Maddalena, Pucci Romano, Rigoni Corinna, Solaroli Carmen, Strumia Renata, Tedeschi Aurora, Antonella Tosti, Vanotti Paola, Zane Cristina

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The aim of the paper has been to study during a period of six month, of the efficacy and the tolerability of both the lotion and shampoo (Timosint®) containing synthetic low molecular weight thymus peptides (GKL02 Factor), in the initial phases of androgen tic alopecia (AGA), and chronic Telogen Effluvium (TE). Ten women (mean age 31,3 yrs) with AGA (Ludwig 1) and 105 female subjects (mean age 39,96 yrs) with chronic TE have been enrolled; The treatment schedule was as follows: - lotion: twice a day application in the first 15 days and then once a day in the following 22 weeks for a total period of treatment of 24 weeks; - shampoo: two or three times /week during the study period of 24 weeks. All the subjects underwent pull test, evaluation of symptoms (dandruff, seborrhea, redness, pruritus). Tolerability and cosmetic acceptance/tolerance were evaluated at the beginning of the treatment and after 30, 90 and 180 days. In AGA patients the improvement of pull test has been continuous becoming negative in study population after 180gg (p = 0,002). Symptomes decreased in all patients. In chronic TE, pull test become negative in 88% (72 cases out of 82) (p<0,0001) with a mean symptoms' improvement of 88%. In both groups the tolerability was referred as positive in 100% of cases and no side effects were recorded. The cosmetic acceptance/tolerance was also referred as positive in 96% of the cases. In conclusion, synthetic thymus peptides showed significant efficacy and tolerability in the clinical treatment of initial AGA and chronic TE in women after a six month-treatment.

Original languageItalian
Pages (from-to)279-285
Number of pages7
JournalJournal of Plastic Dermatology
Volume5
Issue number3
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

Alopecia
Tics
Thymus Gland
Androgens
Peptides
Cosmetics
Dandruff
Seborrheic Dermatitis
Therapeutics
Symptom Assessment
Pruritus
Appointments and Schedules
Molecular Weight
Population

Keywords

  • Androgenetic alopecia and Telogen Effluvium (TE) in women
  • Synthetic thymus peptides
  • Therapy

ASJC Scopus subject areas

  • Dermatology

Cite this

Studio prospettico a sei mesi sugli effetti di un prodotto topico in lozione e shampoo a base di timo-peptidi di sintesi a basso peso molecolare nel telogen effluvium cronico e nell'AGA iniziale della donna. / Gabrielle, Andreassi Maria; Annalisa, Barba; Daniela, Barbaso; Paola, Bassissi; Cristiana, Belloli; Cristiana, Benedetti Maria; Marina, Bertazzoni; Patrizia, Cannavò; Maria, Cantù Alessandra; Rossana, Capezzera; Giuliana, Caporicci; Anna, Carmagnola; Adriana, Ciuffreda; Giovanna, Cocciò; Maria, Costa Carla; Maria Pia, De Padova; Anna, Di Landro; Elisabetta, Domaneschi; Gabriella, Fabbrocini; Caterina, Ferrara; Piera, Fileccia; Giuseppina, Giuliano; Ezia, Lapucci; Sabrina, Lazzerini; Giuseppina, Mazzola; Maddalena, Montalbano; Romano, Pucci; Corinna, Rigoni; Carmen, Solaroli; Renata, Strumia; Aurora, Tedeschi; Tosti, Antonella; Paola, Vanotti; Cristina, Zane.

In: Journal of Plastic Dermatology, Vol. 5, No. 3, 01.09.2009, p. 279-285.

Research output: Contribution to journalArticle

Gabrielle, AM, Annalisa, B, Daniela, B, Paola, B, Cristiana, B, Cristiana, BM, Marina, B, Patrizia, C, Maria, CA, Rossana, C, Giuliana, C, Anna, C, Adriana, C, Giovanna, C, Maria, CC, Maria Pia, DP, Anna, DL, Elisabetta, D, Gabriella, F, Caterina, F, Piera, F, Giuseppina, G, Ezia, L, Sabrina, L, Giuseppina, M, Maddalena, M, Romano, P, Corinna, R, Carmen, S, Renata, S, Aurora, T, Tosti, A, Paola, V & Cristina, Z 2009, 'Studio prospettico a sei mesi sugli effetti di un prodotto topico in lozione e shampoo a base di timo-peptidi di sintesi a basso peso molecolare nel telogen effluvium cronico e nell'AGA iniziale della donna', Journal of Plastic Dermatology, vol. 5, no. 3, pp. 279-285.
Gabrielle, Andreassi Maria ; Annalisa, Barba ; Daniela, Barbaso ; Paola, Bassissi ; Cristiana, Belloli ; Cristiana, Benedetti Maria ; Marina, Bertazzoni ; Patrizia, Cannavò ; Maria, Cantù Alessandra ; Rossana, Capezzera ; Giuliana, Caporicci ; Anna, Carmagnola ; Adriana, Ciuffreda ; Giovanna, Cocciò ; Maria, Costa Carla ; Maria Pia, De Padova ; Anna, Di Landro ; Elisabetta, Domaneschi ; Gabriella, Fabbrocini ; Caterina, Ferrara ; Piera, Fileccia ; Giuseppina, Giuliano ; Ezia, Lapucci ; Sabrina, Lazzerini ; Giuseppina, Mazzola ; Maddalena, Montalbano ; Romano, Pucci ; Corinna, Rigoni ; Carmen, Solaroli ; Renata, Strumia ; Aurora, Tedeschi ; Tosti, Antonella ; Paola, Vanotti ; Cristina, Zane. / Studio prospettico a sei mesi sugli effetti di un prodotto topico in lozione e shampoo a base di timo-peptidi di sintesi a basso peso molecolare nel telogen effluvium cronico e nell'AGA iniziale della donna. In: Journal of Plastic Dermatology. 2009 ; Vol. 5, No. 3. pp. 279-285.
@article{fbd4509712434ca6ad6ac5e00c5d3688,
title = "Studio prospettico a sei mesi sugli effetti di un prodotto topico in lozione e shampoo a base di timo-peptidi di sintesi a basso peso molecolare nel telogen effluvium cronico e nell'AGA iniziale della donna",
abstract = "The aim of the paper has been to study during a period of six month, of the efficacy and the tolerability of both the lotion and shampoo (Timosint{\circledR}) containing synthetic low molecular weight thymus peptides (GKL02 Factor), in the initial phases of androgen tic alopecia (AGA), and chronic Telogen Effluvium (TE). Ten women (mean age 31,3 yrs) with AGA (Ludwig 1) and 105 female subjects (mean age 39,96 yrs) with chronic TE have been enrolled; The treatment schedule was as follows: - lotion: twice a day application in the first 15 days and then once a day in the following 22 weeks for a total period of treatment of 24 weeks; - shampoo: two or three times /week during the study period of 24 weeks. All the subjects underwent pull test, evaluation of symptoms (dandruff, seborrhea, redness, pruritus). Tolerability and cosmetic acceptance/tolerance were evaluated at the beginning of the treatment and after 30, 90 and 180 days. In AGA patients the improvement of pull test has been continuous becoming negative in study population after 180gg (p = 0,002). Symptomes decreased in all patients. In chronic TE, pull test become negative in 88{\%} (72 cases out of 82) (p<0,0001) with a mean symptoms' improvement of 88{\%}. In both groups the tolerability was referred as positive in 100{\%} of cases and no side effects were recorded. The cosmetic acceptance/tolerance was also referred as positive in 96{\%} of the cases. In conclusion, synthetic thymus peptides showed significant efficacy and tolerability in the clinical treatment of initial AGA and chronic TE in women after a six month-treatment.",
keywords = "Androgenetic alopecia and Telogen Effluvium (TE) in women, Synthetic thymus peptides, Therapy",
author = "Gabrielle, {Andreassi Maria} and Barba Annalisa and Barbaso Daniela and Bassissi Paola and Belloli Cristiana and Cristiana, {Benedetti Maria} and Bertazzoni Marina and Cannav{\`o} Patrizia and Maria, {Cant{\`u} Alessandra} and Capezzera Rossana and Caporicci Giuliana and Carmagnola Anna and Ciuffreda Adriana and Cocci{\`o} Giovanna and Maria, {Costa Carla} and {Maria Pia}, {De Padova} and Anna, {Di Landro} and Domaneschi Elisabetta and Fabbrocini Gabriella and Ferrara Caterina and Fileccia Piera and Giuliano Giuseppina and Lapucci Ezia and Lazzerini Sabrina and Mazzola Giuseppina and Montalbano Maddalena and Pucci Romano and Rigoni Corinna and Solaroli Carmen and Strumia Renata and Tedeschi Aurora and Antonella Tosti and Vanotti Paola and Zane Cristina",
year = "2009",
month = "9",
day = "1",
language = "Italian",
volume = "5",
pages = "279--285",
journal = "Journal of Plastic Dermatology",
issn = "2035-0686",
publisher = "International-Italian Society of Plastic and Oncologic Dermatology",
number = "3",

}

TY - JOUR

T1 - Studio prospettico a sei mesi sugli effetti di un prodotto topico in lozione e shampoo a base di timo-peptidi di sintesi a basso peso molecolare nel telogen effluvium cronico e nell'AGA iniziale della donna

AU - Gabrielle, Andreassi Maria

AU - Annalisa, Barba

AU - Daniela, Barbaso

AU - Paola, Bassissi

AU - Cristiana, Belloli

AU - Cristiana, Benedetti Maria

AU - Marina, Bertazzoni

AU - Patrizia, Cannavò

AU - Maria, Cantù Alessandra

AU - Rossana, Capezzera

AU - Giuliana, Caporicci

AU - Anna, Carmagnola

AU - Adriana, Ciuffreda

AU - Giovanna, Cocciò

AU - Maria, Costa Carla

AU - Maria Pia, De Padova

AU - Anna, Di Landro

AU - Elisabetta, Domaneschi

AU - Gabriella, Fabbrocini

AU - Caterina, Ferrara

AU - Piera, Fileccia

AU - Giuseppina, Giuliano

AU - Ezia, Lapucci

AU - Sabrina, Lazzerini

AU - Giuseppina, Mazzola

AU - Maddalena, Montalbano

AU - Romano, Pucci

AU - Corinna, Rigoni

AU - Carmen, Solaroli

AU - Renata, Strumia

AU - Aurora, Tedeschi

AU - Tosti, Antonella

AU - Paola, Vanotti

AU - Cristina, Zane

PY - 2009/9/1

Y1 - 2009/9/1

N2 - The aim of the paper has been to study during a period of six month, of the efficacy and the tolerability of both the lotion and shampoo (Timosint®) containing synthetic low molecular weight thymus peptides (GKL02 Factor), in the initial phases of androgen tic alopecia (AGA), and chronic Telogen Effluvium (TE). Ten women (mean age 31,3 yrs) with AGA (Ludwig 1) and 105 female subjects (mean age 39,96 yrs) with chronic TE have been enrolled; The treatment schedule was as follows: - lotion: twice a day application in the first 15 days and then once a day in the following 22 weeks for a total period of treatment of 24 weeks; - shampoo: two or three times /week during the study period of 24 weeks. All the subjects underwent pull test, evaluation of symptoms (dandruff, seborrhea, redness, pruritus). Tolerability and cosmetic acceptance/tolerance were evaluated at the beginning of the treatment and after 30, 90 and 180 days. In AGA patients the improvement of pull test has been continuous becoming negative in study population after 180gg (p = 0,002). Symptomes decreased in all patients. In chronic TE, pull test become negative in 88% (72 cases out of 82) (p<0,0001) with a mean symptoms' improvement of 88%. In both groups the tolerability was referred as positive in 100% of cases and no side effects were recorded. The cosmetic acceptance/tolerance was also referred as positive in 96% of the cases. In conclusion, synthetic thymus peptides showed significant efficacy and tolerability in the clinical treatment of initial AGA and chronic TE in women after a six month-treatment.

AB - The aim of the paper has been to study during a period of six month, of the efficacy and the tolerability of both the lotion and shampoo (Timosint®) containing synthetic low molecular weight thymus peptides (GKL02 Factor), in the initial phases of androgen tic alopecia (AGA), and chronic Telogen Effluvium (TE). Ten women (mean age 31,3 yrs) with AGA (Ludwig 1) and 105 female subjects (mean age 39,96 yrs) with chronic TE have been enrolled; The treatment schedule was as follows: - lotion: twice a day application in the first 15 days and then once a day in the following 22 weeks for a total period of treatment of 24 weeks; - shampoo: two or three times /week during the study period of 24 weeks. All the subjects underwent pull test, evaluation of symptoms (dandruff, seborrhea, redness, pruritus). Tolerability and cosmetic acceptance/tolerance were evaluated at the beginning of the treatment and after 30, 90 and 180 days. In AGA patients the improvement of pull test has been continuous becoming negative in study population after 180gg (p = 0,002). Symptomes decreased in all patients. In chronic TE, pull test become negative in 88% (72 cases out of 82) (p<0,0001) with a mean symptoms' improvement of 88%. In both groups the tolerability was referred as positive in 100% of cases and no side effects were recorded. The cosmetic acceptance/tolerance was also referred as positive in 96% of the cases. In conclusion, synthetic thymus peptides showed significant efficacy and tolerability in the clinical treatment of initial AGA and chronic TE in women after a six month-treatment.

KW - Androgenetic alopecia and Telogen Effluvium (TE) in women

KW - Synthetic thymus peptides

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=77649112258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649112258&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 279

EP - 285

JO - Journal of Plastic Dermatology

JF - Journal of Plastic Dermatology

SN - 2035-0686

IS - 3

ER -